Severe vision loss secondary to retinal arteriolar occlusions after multiple intravitreal brolucizumab administrations-Reference-Cited by-同舟云学术

Severe vision loss secondary to retinal arteriolar occlusions after multiple intravitreal brolucizumab administrations

Published:2020-06 Issue: Volume:18 Page:100687
ISSN:2451-9936
Container-title:American Journal of Ophthalmology Case Reports
language:en
Short-container-title:American Journal of Ophthalmology Case Reports

Author:

Jain Atul,Chea Sophaktra,Matsumiya Wataru^ORCID,Halim M. Sohail,Yaşar Çigdem,Kuang Guoping,Sepah Yasir J.,Khanani Arshad M.,Do Diana V.,Nguyen Quan Dong

Publisher

Elsevier BV

Subject

Ophthalmology

Reference19 articles.

1. Ranibizumab for neovascular age-related macular degeneration;Hernandez-Pastor;Am J Health Syst Pharm: Offc J Am Soc Health Sys Pharama,2008

3. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis;Wong;Lancet Glob health,2014

4. Brolucizumab versus aflibercept in participants with neovascular age-related macular degeneration: a randomized trial;Dugel;Ophthalmology,2017

5. HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration;Dugel;Ophthalmology,2020

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on Retinal Drug Safety: Proceedings of the ASRS ReST Committee Webinar Part 1;Journal of VitreoRetinal Diseases;2024-08-22

2. Intra-Ocular Inflammation and Occlusive Retinal Vasculitis Following Intravitreal Injections of Faricimab: A Case Report;Ocular Immunology and Inflammation;2024-06-10

3. Retreatment with faricimab in prior brolucizumab-related intraocular inflammation eyes;Taiwan Journal of Ophthalmology;2024-04-26

4. Visual outcomes of intraocular inflammation after brolucizumab injection in Japanese patients with neovascular age-related macular degeneration;PLOS ONE;2024-04-18

5. Retinal pigment epithelium rip with posterior uveitis after intravitreal brolucizumab in neovascular age-related macular degeneration;Indian Journal of Ophthalmology;2024-01-25